DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
GS-441524
1
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
GS-441524
×
Maximum Phase:
1
First Approval:
None
UNII:
1BQK176DT6
Molecule Type:
Small molecule
Molecular Formula:
C12H13N5O4
Molecular Weight:
291.27
AlogP:
-1.86
PSA:
149.92
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ARDENERMIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
ARDENERMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9B1I11GZRB
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVP-21D9
1
Antibody
Investigational
Unknown
Unknown
Anthrax
Protective antigen inhibitor
AVP-21D9
×
Maximum Phase:
1
First Approval:
None
UNII:
6RUU8A4K0R
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SB-743921
1
Small molecule
Investigational
Unknown
Unknown
Hodgkin Disease; Lymphoma, Non-Hodgkin; Neoplasms
Unknown
SB-743921
×
Maximum Phase:
1
First Approval:
None
UNII:
24DSZ1VN92
Molecule Type:
Small molecule
Molecular Formula:
C31H33ClN2O3
Molecular Weight:
517.07
AlogP:
6.53
PSA:
76.54
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AV-380
1
Unknown
Investigational
Unknown
Unknown
Cachexia
Unknown
AV-380
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-9977
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Kidney Diseases
Mineralocorticoid receptor modulator
AZD-9977
×
Maximum Phase:
1
First Approval:
None
UNII:
6C9UKZ0CYE
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN3O5
Molecular Weight:
399.38
AlogP:
1.7
PSA:
96.97
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PALOMID-529
1
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration
Serine/threonine-protein kinase mTOR inhibitor
PALOMID-529
×
Maximum Phase:
1
First Approval:
None
UNII:
XV9409EWG4
Molecule Type:
Small molecule
Molecular Formula:
C24H22O6
Molecular Weight:
406.43
AlogP:
4.6
PSA:
78.13
HBD:
1.0
HBA:
#RotB:
6.0
Source:
N-ACETYLGLUCOSAMINE
1
Small molecule
Investigational
Unknown
Unknown
Malnutrition
Unknown
N-ACETYLGLUCOSAMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
8P59336F68
Molecule Type:
Small molecule
Molecular Formula:
C8H15NO6
Molecular Weight:
221.21
AlogP:
-3.08
PSA:
119.25
HBD:
5.0
HBA:
#RotB:
2.0
Source:
RAD-140
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
RAD-140
×
Maximum Phase:
1
First Approval:
None
UNII:
4O87Q44KNC
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN5O2
Molecular Weight:
393.83
AlogP:
3.98
PSA:
118.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TC-2216
1
Small molecule
Investigational
Unknown
Unknown
Anxiety; Depressive Disorder
Neuronal acetylcholine receptor; alpha4/beta2 antagonist
TC-2216
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H17N3
Molecular Weight:
203.29
AlogP:
1.41
PSA:
28.16
HBD:
1.0
HBA:
#RotB:
1.0
Source:
IGN-311
1
Antibody
Investigational
Unknown
Unknown
Unknown
Lewis Y antigen binding agent
IGN-311
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SOR-C13
1
Protein
Investigational
Unknown
Unknown
Neoplasms
Unknown
SOR-C13
×
Maximum Phase:
1
First Approval:
None
UNII:
C79B5A73C4
Molecule Type:
Protein
Molecular Formula:
C72H116N20O19
Molecular Weight:
1565.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
INULINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INULINE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C32H46N2O8
Molecular Weight:
586.73
AlogP:
1.72
PSA:
132.94
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Leukemia
Interleukin-2 receptor beta chain inhibitor
MIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VAPALIXIMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
VAPALIXIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
M1EGR25LBB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTX-660
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma
Unknown
ASTX-660
×
Maximum Phase:
1
First Approval:
None
UNII:
2LHZ9ZC3YO
Molecule Type:
Small molecule
Molecular Formula:
C30H42FN5O3
Molecular Weight:
539.7
AlogP:
2.31
PSA:
81.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
EMB-01
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
EMB-01
×
Maximum Phase:
1
First Approval:
None
UNII:
G86X5QQ7M5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-3415244
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
LY-3415244
×
Maximum Phase:
1
First Approval:
None
UNII:
603H2FWG4N
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHROMIUM PICOLINATE
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Feeding and Eating Disorders
Unknown
CHROMIUM PICOLINATE
×
Maximum Phase:
1
First Approval:
None
UNII:
S71T8B8Z6P
Molecule Type:
Small molecule
Molecular Formula:
C18H12CrN3O6
Molecular Weight:
417.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RO-7296682
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
RO-7296682
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUDIGALIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma
Programmed cell death protein 1 inhibitor
BUDIGALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
6VDO4TY3OO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R(+)XK469
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Neuroblastoma
Unknown
R(+)XK469
×
Maximum Phase:
1
First Approval:
None
UNII:
8VSJ573G09
Molecule Type:
Small molecule
Molecular Formula:
C17H13ClN2O4
Molecular Weight:
344.75
AlogP:
3.93
PSA:
81.54
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RXDX-103
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cell division cycle 7-related protein kinase inhibitor
RXDX-103
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DI-LEU16-IL2
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Follicular
Unknown
DI-LEU16-IL2
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SB-756050
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
SB-756050
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O8S2
Molecular Weight:
500.6
AlogP:
1.81
PSA:
111.68
HBD:
0.0
HBA:
#RotB:
8.0
Source:
POSIPHEN
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
POSIPHEN
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARC1905
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ARC1905
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAR-441236
1
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
SAR-441236
×
Maximum Phase:
1
First Approval:
None
UNII:
XKF7EDC32B
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-6918
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
AZD-6918
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SS1(DSFV)-PE38
1
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Mesothelioma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Uterine Cervical Neoplasms
Mesothelin binding agent
SS1(DSFV)-PE38
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELUBRIXIN TOSYLATE
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
ELUBRIXIN TOSYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
13FVR7WD4P
Molecule Type:
Small molecule
Molecular Formula:
C24H25Cl2FN4O7S2
Molecular Weight:
635.52
AlogP:
3.08
PSA:
110.77
HBD:
4.0
HBA:
#RotB:
4.0
Source:
S-222611
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
S-222611
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-548
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
AMG-548
×
Maximum Phase:
1
First Approval:
None
UNII:
PGR0H531I4
Molecule Type:
Small molecule
Molecular Formula:
C29H27N5O
Molecular Weight:
461.57
AlogP:
4.64
PSA:
85.83
HBD:
2.0
HBA:
#RotB:
7.0
Source:
EMD-1204831
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
EMD-1204831
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GUSUIBU
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
GUSUIBU
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
120
121
122
123
124
125
126
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA